DAVID PAGE: Open Payments
NPI 1598768848 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 112 payments from 19 companies in 2025. Trend: 2023 $1,969 · 2024 $2,294 · 2025 $2,121
Food & beverage: $2,121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $453 |
| Vanda Pharmaceuticals Inc. | 10 | $380 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $257 |
| AstraZeneca Pharmaceuticals LP | 4 | $203 |
| Novo Nordisk Inc | 16 | $200 |
| PFIZER INC. | 5 | $101 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
Products named: FANAPT, CAPLYTA, Ozempic, QULIPTA, UBRELVY, VRAYLAR, FARXIGA, REXULTI.
Industry payments across IN — which companies pay providers there.
